Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

TGFβ Programs Central Memory Differentiation in Ex Vivo-Stimulated Human T Cells.

Dahmani A, Janelle V, Carli C, Richaud M, Lamarche C, Khalili M, Goupil M, Bezverbnaya K, Bramson JL, Delisle JS.

Cancer Immunol Res. 2019 Sep;7(9):1426-1439. doi: 10.1158/2326-6066.CIR-18-0691. Epub 2019 Jul 15.

PMID:
31308016
2.

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.

Helsen CW, Hammill JA, Lau VWC, Mwawasi KA, Afsahi A, Bezverbnaya K, Newhook L, Hayes DL, Aarts C, Bojovic B, Denisova GF, Kwiecien JM, Brain I, Derocher H, Milne K, Nelson BH, Bramson JL.

Nat Commun. 2018 Aug 3;9(1):3049. doi: 10.1038/s41467-018-05395-y.

3.

Tumor-targeting domains for chimeric antigen receptor T cells.

Bezverbnaya K, Mathews A, Sidhu J, Helsen CW, Bramson JL.

Immunotherapy. 2017 Jan;9(1):33-46. doi: 10.2217/imt-2016-0103. Review.

PMID:
28000526
4.

Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Liu Y, Bezverbnaya K, Zhao T, Parsons MJ, Shi M, Treanor B, Ehrhardt GR.

J Immunol. 2015 Jun 15;194(12):5851-60. doi: 10.4049/jimmunol.1401533. Epub 2015 May 13.

Supplemental Content

Loading ...
Support Center